Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
CNY 12.08
(1.34%)
CNY 12.08
(1.34%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 189.99 Million CNY | 81.34% |
| 2022 | 104.77 Million CNY | 23.45% |
| 2021 | 84.87 Million CNY | -41.38% |
| 2020 | 144.79 Million CNY | -2.11% |
| 2019 | 147.92 Million CNY | 33.74% |
| 2018 | 110.59 Million CNY | 169.94% |
| 2017 | 40.97 Million CNY | -66.35% |
| 2016 | 121.77 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 38.13 Million CNY | -19.09% |
| 2024 Q2 | 41.77 Million CNY | 9.54% |
| 2024 Q3 | 67.76 Million CNY | 66.53% |
| 2023 Q2 | 64.64 Million CNY | 29.51% |
| 2023 FY | 189.99 Million CNY | 81.34% |
| 2023 Q4 | 47.13 Million CNY | 66.32% |
| 2023 Q3 | 28.33 Million CNY | -56.16% |
| 2023 Q1 | 49.91 Million CNY | 4.1% |
| 2022 Q3 | 29.53 Million CNY | 77.7% |
| 2022 FY | 104.77 Million CNY | 23.45% |
| 2022 Q2 | 16.61 Million CNY | 55.74% |
| 2022 Q1 | 10.67 Million CNY | -21.12% |
| 2022 Q4 | 47.94 Million CNY | 62.36% |
| 2021 Q2 | 23.25 Million CNY | -23.95% |
| 2021 Q1 | 30.57 Million CNY | -37.03% |
| 2021 Q4 | 13.52 Million CNY | -22.74% |
| 2021 Q3 | 17.5 Million CNY | -24.72% |
| 2021 FY | 84.87 Million CNY | -41.38% |
| 2020 Q2 | 47.75 Million CNY | 151.39% |
| 2020 Q1 | 18.99 Million CNY | -70.66% |
| 2020 FY | 144.79 Million CNY | -2.11% |
| 2020 Q4 | 48.55 Million CNY | 64.69% |
| 2020 Q3 | 29.48 Million CNY | -38.26% |
| 2019 Q4 | 64.75 Million CNY | 267.29% |
| 2019 Q2 | 32.24 Million CNY | -3.13% |
| 2019 Q1 | 33.28 Million CNY | 0.0% |
| 2019 FY | 147.92 Million CNY | 33.74% |
| 2019 Q3 | 17.63 Million CNY | -45.32% |
| 2018 FY | 110.59 Million CNY | 169.94% |
| 2017 FY | 40.97 Million CNY | -66.35% |
| 2016 FY | 121.77 Million CNY | 0.0% |